News from the MCRC
New research can help policymakers prioritise funding needs and allocate resource for cancer
The study found that 61% of all SPED trials focused on just three cancer types – colorectal, breast, and cervical cancer.
MCRC Director’s Update – September 2023
September sees us celebrate the successes of our research community and spotlight RAPID-RT and other precision medicine trials.
RAPID-RT: New study aims to improve survival rates for lung cancer patients
The trial aims to identify whether sparing the top of the heart during radiotherapy can help patients with lung cancer live longer.
15 outstanding NHS clinicians and researchers named MAHSC Honorary Clinical Chairs 2023
Recognising individuals who have made a major contribution to their clinical specialty, including excellence in research and education
MCRC Director’s Update – Summer 2023
This summer, the MCRC welcomed members of the community to co-create research projects, celebrated the achievements of our MB-PhD and academic colleagues, and launch the MCRC Springboard Award designed to help researchers accelerate the translation of their discoveries.
One in Two: A Manchester Cancer Research Podcast with Fabio Gomes
We speak to Dr Fabio Gomes about never smokers and the ALK positive mutation in Non-Small Cell Lung Cancer (NSCLC).
Study improves accuracy of predictive breast cancer genetic test for Ashkenazi Jewish women
Manchester researchers have developed a way to improve the accuracy of breast cancer genetic testing for women from Ashkenazi Jewish backgrounds.
One in Two: A Manchester Cancer Research Podcast
We speak to Professor Caroline Dive about cancer biomarkers and how liquid biopsies could pave the way for lung cancer detection and treatment.